Future studies aimed at evaluating NLRC5 expression and mutations in a larger number of lymphoid tumor cells, and in primary tumors will contribute to delineate the potential importance of NLRC5 in tumor progression. The gene discussed is NLRC5; the disease is lymphoid neoplasm.